The Project Bioshield Act, passed in 2004, provided companies with liability protection if a product was used for emergency purposes, but had not yet completed all final stages of approval by the U.S. Food and Drug Administration (FDA).

Question

Quizplus · Accepted Answer

The Project Bioshield Act of 2004 was primarily aimed at expediting the development and procurement of medical countermeasures against chemical, biological, radiological, and nuclear threats, but it did not specifically provide liability protection for companies. Liability protection was addressed in the Public Readiness and Emergency Preparedness (PREP) Act of 2005.

The Project Bioshield Act, Passed in 2004, Provided Companies with Liability